Use of a MCL-1 inhibitor alone to de-bulk melanoma and in combination to kill melanoma initiating cells.
about
Therapeutic implications of cellular and molecular biology of cancer stem cells in melanoma.Combining a GSI and BCL-2 inhibitor to overcome melanoma's resistance to current treatments.Regulatory role of sphingosine kinase and sphingosine-1-phosphate receptor signaling in progenitor/stem cellsBH3 mimetics induce apoptosis independent of DRP-1 in melanoma
P2860
Use of a MCL-1 inhibitor alone to de-bulk melanoma and in combination to kill melanoma initiating cells.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Use of a MCL-1 inhibitor alone ...... ill melanoma initiating cells.
@en
type
label
Use of a MCL-1 inhibitor alone ...... ill melanoma initiating cells.
@en
prefLabel
Use of a MCL-1 inhibitor alone ...... ill melanoma initiating cells.
@en
P2093
P2860
P356
P1433
P1476
Use of a MCL-1 inhibitor alone ...... ill melanoma initiating cells.
@en
P2093
Adam Almeida
Chung-Wai Shiau
David A Norris
Jung-Chen Su
Karoline Lambert
Mayumi Fujita
Nabanita Mukherjee
Steven E Robinson
William A Robinson
P2860
P304
46801-46817
P356
10.18632/ONCOTARGET.8695
P407
P577
2016-04-12T00:00:00Z